Markets:

Overview

News

Currencies

International

Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

116.81 +2.37 (+2.07%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Illumina, Inc. - Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

25 26 Next >

The Top 3 Stocks in the High-Potential ‘Cancer Testing’ Market ↗

January 18, 2024

With the value of the cancer testing market expected to soar over the next decade, here are the three best disease testing stocks to buy now.

Via InvestorPlace

7 Mighty Healthcare Stocks Changing the Game of Medicine ↗

January 17, 2024

Thanks to the permanent relevance of medical innovations, investors ought to consider looking at these healthcare stocks.

Via InvestorPlace

10 Health Care Stocks With Whale Alerts In Today's Session ↗

January 16, 2024

Via Benzinga

Biotech Playbook: Small Caps Show Momentum Peaking During ↗

January 15, 2024

The momentum of selected stocks was strong up until early January was encouraging but we need less volatility in period ahead to conform a new bull market.

Via Talk Markets

Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 09, 2024

Shares of JetBlue Airways Corporation (NASDAQ: JBLU) fell sharply during Tuesday’s session.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

January 09, 2024

Via Benzinga

Illumina Shares Trading Higher After Confirming Partnership With Johnson & Johnson Unit ↗

January 09, 2024

Illumina, Inc. (NASDAQ: ILMN) shares are trading higher after announcing preliminary financial results for the fourth quarter (Q4) and

Via Benzinga

Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday ↗

January 09, 2024

U.S. stocks traded lower, with the Dow Jones index falling over 250 points on Tuesday.

Via Benzinga

Topics Stocks

Why Illumina Rallied 36.6% in December ↗

January 09, 2024

The beaten-down gene sequencing company is getting a further shakeup.

Via The Motley Fool

Deep Dive Into Illumina Stock: Analyst Perspectives (9 Ratings) ↗

January 04, 2024

Via Benzinga

Illumina To Sell Grail After U.S. Antitrust Ruling ↗

December 17, 2023

The $7.1 billion deal has faced major regulatory opposition.

Via Investor's Business Daily

Analyst Expectations for Illumina's Future ↗

December 11, 2023

Via Benzinga

Illumina's MRD Technology For Cancer Testing Collaborates With Johnson & Johnson Unit ↗

January 05, 2024

Illumina, Inc. (NASDAQ: ILMN) announced it has signed an agreement with Janssen Research & Development, a unit of Johnson & Johnson (NYSE: JNJ).

Via Benzinga

Small Caps Are On A Tear Including Speculative Biotechs ↗

December 26, 2023

So far 2023 is going well with our game plan -an end-of-year seasonal rally coupled with a run in speculative biotechs driven by innovation.

Via Talk Markets

Stock Market Rally Is In Merry Mood Heading Into Christmas Weekend: Weekly Review ↗

December 22, 2023

Despite a Wednesday tumble, the major indexes are right at 2023 highs.

Via Investor's Business Daily

Tech Stocks Set New All-Time High, Small Caps On Fire As Wall Street Bulls Run Wild: What's Driving Markets Tuesday? ↗

December 19, 2023

Tuesday, December 19, 2023, stands now as a remarkable day in Wall Street’s history, as the technology stocks of the Nasdaq 100 mark a significant milestone, surging to new highs after a hiatus of 758...

Via Benzinga

Carl Icahn Escalates Boardroom Battle At Illumina, Seeks To Remove More Directors After Grail Divestiture ↗

December 19, 2023

Activist investor Carl Icahn said on Monday that he plans to oust legacy conflicted directors at Illumina Inc (NASDAQ: ILMN), laying the groundwork for a second board challenge at the San Diego...

Via Benzinga

Illumina-Grail $8B Saga Ends After It Battles Regulators For 3 Years ↗

December 18, 2023

On Sunday, gene-sequencing company Illumina Inc (NASDAQ: ILMN) agreed to divest cancer diagnostic test maker Grail Inc as the companies battled with the U.S.

Via Benzinga

Illumina Stock Rises On Plans To Divest Controversial Buyout Grail ↗

December 18, 2023

Illumina has been in hot regulatory water since the decision to acquire Grail in 2021.

Via Investor's Business Daily

10 Health Care Stocks Whale Activity In Today's Session ↗

December 14, 2023

Via Benzinga

Illumina Analyst Optimistic On Company's Prospects For 'Accelerated Growth' ↗

December 14, 2023

Illumina, Inc. (NASDAQ: ILMN) has come to loggerheads with EU antitrust regulators related to their investigation into the $7.1 billion acquisitio

Via Benzinga

Illumina Versus European Commission: Legal Battle Over Grail Acquisition Reaches Critical Stage ↗

December 12, 2023

Illumina Inc (NASDAQ: ILMN) reportedly clashed with EU antitrust regulators, alleging an overreach in their investigation into its

Via Benzinga

Black Friday On Wall Street: 10 S&P 500 Stocks Trading At 40%+ Discount From Analysts' Expectations ↗

November 24, 2023

Several S&P 500 stocks are trading at discounts of over 40% compared to analysts' price targets, offering potential upside, but caution is needed.

Via Benzinga

Topics Stocks

Half Of S&P 500 Stocks Still Below 200-Day Average, Ignoring Covid-Like Rally: 10 Bargain Plays For Latecomer Bulls ↗

November 21, 2023

Explore the dichotomy in the latest S&P 500 rally: Strong overall performance masks the underperformance of nearly half its stocks.

Via Benzinga

Topics Stocks

Why Illumina Inc Stock Is Falling ↗

November 10, 2023

llumina, Inc. (NASDAQ: ILMN) shares are trading lower Friday after the company reported mixed third-quarter financial results on Thursday.

Via Benzinga

Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

November 10, 2023

Shares of Wynn Resorts, Limited (NASDAQ: WYNN) fell sharply on Friday after the company reported third-quarter financial results.

Via Benzinga

DNA-Reading Giant Illumina Crashes As Macro Pressures Guidance — Again ↗

November 10, 2023

Illumina expects flat growth in 2024, which lines up with other life sciences tools companies.

Via Investor's Business Daily

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 10, 2023

Via Benzinga

Synaptics To Rally Over 41%? Here Are 10 Top Analyst Forecasts For Friday ↗

November 10, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

US Stocks Could Wobble As Powell's Inflation Obsession Intensifies Rate Uncertainty: Will Nasdaq Wipe Off Week's Gains? ↗

November 10, 2023

U.S. stocks are priming for a lackluster open on Friday, with the index futures trading on a narrowly mixed note. Interest rate worries have likely perked up, as reflected by the upward move in bond...

Via Benzinga

Topics Bonds Economy

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

25 26 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Illumina, Inc. - Common Stock (NQ:ILMN)

Headline News about Illumina, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today